These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21352159)
1. Case reports: an opportunity for early intervention: velo-cardio-facial syndrome and psychosis. Starling J; Harris AW Early Interv Psychiatry; 2008 Nov; 2(4):262-7. PubMed ID: 21352159 [TBL] [Abstract][Full Text] [Related]
2. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Gothelf D; Schaer M; Eliez S Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637 [TBL] [Abstract][Full Text] [Related]
3. The velo-cardio-facial syndrome: the spectrum of psychiatric problems and cognitive deterioration at adult age. Evers LJ; De Die-Smulders CE; Smeets EE; Clerkx MG; Curfs LM Genet Couns; 2009; 20(4):307-15. PubMed ID: 20162865 [TBL] [Abstract][Full Text] [Related]
5. [Velo-cardio-facial syndrome at the psychiatry consulting-liaison service in a general hospital]. Fernández-Egea E; Ferrer del Alamo A; Torrebadell Burriel M; Carrió Ybáñez A Actas Esp Psiquiatr; 2006; 34(1):67-8. PubMed ID: 16525908 [TBL] [Abstract][Full Text] [Related]
6. The facial phenotype of the velo-cardio-facial syndrome. Butts SC Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):343-50. PubMed ID: 19062108 [TBL] [Abstract][Full Text] [Related]
7. Velo-cardio-facial syndrome: 30 Years of study. Shprintzen RJ Dev Disabil Res Rev; 2008; 14(1):3-10. PubMed ID: 18636631 [TBL] [Abstract][Full Text] [Related]
8. Encoding and retrieval processes in velo-cardio-facial syndrome (VCFS). Debbané M; Glaser B; Eliez S Neuropsychology; 2008 Mar; 22(2):226-34. PubMed ID: 18331165 [TBL] [Abstract][Full Text] [Related]
9. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal trajectories of cortical thickness as a biomarker for psychosis in individuals with 22q11.2 deletion syndrome. Ramanathan S; Mattiaccio LM; Coman IL; Botti JC; Fremont W; Faraone SV; Antshel KM; Kates WR Schizophr Res; 2017 Oct; 188():35-41. PubMed ID: 27988073 [TBL] [Abstract][Full Text] [Related]
18. [High risk for psychosis in velo-cardio-facial sydnrome. Description of symptoms and a case report]. Jönsson S; Björkman A; Schultz L; Kristoffersson U Lakartidningen; 1997 Jan; 94(5):329-31. PubMed ID: 9053672 [No Abstract] [Full Text] [Related]
19. Velo-cardio-facial and partial DiGeorge phenotype in a child with interstitial deletion at 10p13--implications for cytogenetics and molecular biology. Lipson A; Fagan K; Colley A; Colley P; Sholler G; Issacs D; Oates RK Am J Med Genet; 1996 Nov; 65(4):304-8. PubMed ID: 8923940 [TBL] [Abstract][Full Text] [Related]
20. The neurocognitive phenotype in velo-cardio-facial syndrome: a developmental perspective. Antshel KM; Fremont W; Kates WR Dev Disabil Res Rev; 2008; 14(1):43-51. PubMed ID: 18636636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]